A. Kohls

789 total citations
13 papers, 104 citations indexed

About

A. Kohls is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Kohls has authored 13 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in A. Kohls's work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and HER2/EGFR in Cancer Research (4 papers). A. Kohls is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and HER2/EGFR in Cancer Research (4 papers). A. Kohls collaborates with scholars based in Germany, Netherlands and United States. A. Kohls's co-authors include Jens‐Uwe Blohmer, Dirk Elling, Sherko Kümmel, G. P. Breitbach, G Morack, W. Lichtenegger, Sherko Küemmel, Uwe Köhler, Hans Guski and Holm Eggemann and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

A. Kohls

13 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Kohls Germany 6 74 62 18 17 13 13 104
M. Debled France 6 57 0.8× 50 0.8× 15 0.8× 13 0.8× 16 1.2× 16 85
Gayle DiLalla United States 6 64 0.9× 54 0.9× 22 1.2× 11 0.6× 16 1.2× 19 101
Francis Aitpillah Ghana 6 98 1.3× 58 0.9× 14 0.8× 7 0.4× 14 1.1× 10 139
Patrick Kirchweger Austria 7 59 0.8× 39 0.6× 36 2.0× 33 1.9× 15 1.2× 19 105
Angela Stefania Ribecco Italy 7 59 0.8× 21 0.3× 25 1.4× 12 0.7× 7 0.5× 13 91
Annelisa Marsella Italy 4 49 0.7× 52 0.8× 8 0.4× 10 0.6× 12 0.9× 5 92
Béla Pikó Hungary 5 59 0.8× 22 0.4× 19 1.1× 9 0.5× 7 0.5× 20 89
L Galletto Italy 5 58 0.8× 16 0.3× 16 0.9× 32 1.9× 16 1.2× 8 166
B. Valenza France 6 67 0.9× 31 0.5× 34 1.9× 9 0.5× 7 0.5× 10 91
Chu Van Nguyen Vietnam 7 62 0.8× 26 0.4× 37 2.1× 11 0.6× 21 1.6× 36 114

Countries citing papers authored by A. Kohls

Since Specialization
Citations

This map shows the geographic impact of A. Kohls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kohls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kohls more than expected).

Fields of papers citing papers by A. Kohls

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kohls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kohls. The network helps show where A. Kohls may publish in the future.

Co-authorship network of co-authors of A. Kohls

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kohls. A scholar is included among the top collaborators of A. Kohls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kohls. A. Kohls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Schouten, Philip C., Karsten E. Weber, Valentina Nekljudova, et al.. (2017). BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial. Breast Cancer Research and Treatment. 166(3). 775–785. 2 indexed citations
3.
4.
Kümmel, Sherko, A. Kohls, G. P. Breitbach, et al.. (2006). Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: Feasibility and tolerability in a subset of patients in a randomized trial. Critical Reviews in Oncology/Hematology. 58(2). 166–175. 9 indexed citations
5.
Kümmel, Sherko, A. Kohls, G. P. Breitbach, et al.. (2006). Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer. British Journal of Cancer. 94(9). 1237–1244. 40 indexed citations
6.
Kümmel, Sherko, Anke Thomas, Stefan Paepke, et al.. (2005). Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A phase II study. Acta Oncologica. 44(3). 248–254. 5 indexed citations
7.
8.
Küemmel, Sherko, A. Kohls, G. P. Breitbach, et al.. (2004). A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes. Journal of Clinical Oncology. 22(14_suppl). 589–589. 15 indexed citations
9.
Küemmel, Sherko, A. Kohls, G. P. Breitbach, et al.. (2004). A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes. Journal of Clinical Oncology. 22(14_suppl). 589–589. 1 indexed citations
10.
11.
Kümmel, Sherko, Jens‐Uwe Blohmer, W. Lichtenegger, et al.. (2000). [Dose intensified adjuvant chemotherapy in high risk breast carcinoma with 4-9 positive lymph nodes].. PubMed. 122(4). 207–16. 3 indexed citations
12.
Blohmer, Jens‐Uwe, et al.. (1999). Increased Incidence of Cervical Intraepithelial Neoplasia in Young Women in the Mitte District, Berlin, Germany. Acta Cytologica. 43(2). 195–200. 7 indexed citations
13.
Kohls, A.. (1998). [Oncoplastic variations in surgical treatment of pT2 breast carcinoma].. PubMed. 123 Suppl 5. 113–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Debled Breakdown of academic impact, for papers by Gayle DiLalla Breakdown of academic impact, for papers by Francis Aitpillah Breakdown of academic impact, for papers by Patrick Kirchweger Breakdown of academic impact, for papers by Angela Stefania Ribecco Breakdown of academic impact, for papers by Annelisa Marsella Breakdown of academic impact, for papers by Béla Pikó Breakdown of academic impact, for papers by L Galletto Breakdown of academic impact, for papers by B. Valenza Breakdown of academic impact, for papers by Chu Van Nguyen
Rankless by CCL
2026